Related Experiment Video
Updated: Jun 18, 2026

Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina
Published on: May 6, 2015
Longitudinal Assessment of Cone Structure, Choriocapillaris, and Retinal Sensitivity in Choroideremia
Liangbo Linus Shen1, Yi Zhang2, Jessica Wong1
1Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States.
Purpose:
To investigate longitudinal changes in cone structure, choriocapillaris, and retinal sensitivity in choroideremia.
Methods:
We assessed cone spacing z scores using adaptive optics scanning light ophthalmoscopy, analyzed choriocapillaris flow deficits (CCFDs) on swept-source optical coherence tomography angiography, and measured retinal sensitivity via microperimetry. Linear mixed-effects models estimated annual change rates in these parameters.
Results:
We analyzed 225 regions of interest from 14 eyes of 7 participants with choroideremia, including 6 participants (12 eyes) with follow-up imaging over a median of 3.3 years. The cone spacing z score increased by 0.57 ± 0.18 per year (P = 0.02), independent of distance to the fundus autofluorescence (FAF) border (P = 0.92). CCFD increased by 3.43 ± 0.52% per year at 1° inside (P < 0.001) and 2.03 ± 0.73% per year at 1° outside the FAF border (P = 0.01), but did not change significantly in other regions. Retinal sensitivity changed by -1.50 ± 0.34 dB/year at 1° inside (P < 0.001) and -1.94 ± 0.52 dB/year at 1° outside (P = 0.001) the FAF border, but did not change significantly in other areas. Greater retinal sensitivity loss correlated with closer proximity to the FAF border, greater baseline sensitivity, greater cone spacing z score, and larger CCFDs (P < 0.001 for each).
Conclusions:
Cone spacing z score increased uniformly within the residual macular area, and CCFD and retinal sensitivity changed more rapidly within 1° of the FAF border. Regions in this zone are projected to lose 7 dB of sensitivity in approximately 3.5 years, shedding light into future clinical trial design.

